HPV-Induced Cancers Market: Industry Analysis, Epidemiology, Pipeline Therapies, Companies
- Ankit Nigam
- Sep 13, 2021
- 3 min read
Human papillomavirus (HPV) is a double-stranded DNA virus that infects squamous cells such as skin, oral, vaginal, anal, and nasal epithelium. The basal cells in the epithelium are the targets and, once infected, act as the reservoir for the virus. Viral replication occurs mainly in the epithelial cells that have completed cell division and are progressing to desquamation. Desquamation releases the viral particles and completes the viral replication cycle. Worldwide, the major oncogenic HPV subtypes are 16 and 18, which account for most of the HPV-related cancers.
DelveInsight's "HPV-Induced Cancers Market Insights, Epidemiology, and Market Forecast-2030" report delivers an in-depth understanding of the HPV-Induced Cancers, historical and forecasted epidemiology as well as the HPV-Induced Cancers market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Some Key facts of HPV-Induced Cancers Market are:
· The total incident cases of HPV-induced Cancer in the 7MM were 99,392 in 2020.
· The HPV-induced Cancer market size in the 7MM was USD 710 Million in 2020, and the market is estimated to increase during the study period (2018–2030).
· Major players include ISA Pharmaceuticals’s ISA101b and PDS Biotechnology’s PDS0101 being assessed as potential therapies available in the market in the future.
· Currently, there are three commercially available HPV vaccines: Cervarix, a bivalent HPV-16/18 vaccine; Gardasil, a quadrivalent HPV-6/11/16/18 vaccine; and Gardasil9, a nonavalent HPV-6/11/16/18/31/33/45/52/58 vaccine. These components have been included in the forecast model to calculate the approximate revenue estimates during the study period [2018–2030].
Request for Free Sample Report: https://www.delveinsight.com/sample-request/hpv-induced-cancers-market
Scope of HPV-Induced Cancers Market Report:
The report covers the descriptive overview of HPV-Induced Cancers, explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies
Comprehensive insight has been provided into the HPV-Induced Cancers epidemiology and treatment in the 7MM
Additionally, an all-inclusive account of both the current and emerging therapies for HPV-Induced Cancers are provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape
A detailed review of HPV-Induced Cancers market; historical and forecasted is included in the report, covering drug outreach in the 7MM
The report provides an edge while developing business strategies, by understanding trends shaping and driving the global HPV-Induced Cancers market
· Merck
· GlaxoSmithKline
· PDS Biotechnology
· Cue Biopharma
· ISA Pharmaceuticals/Regeneron Pharmaceuticals
· Vaccibody AS/Roche
· Transgene
· Innovio Pharma
· Hookipa Pharma
· Roche Pharma AG/Invectys
· BioNTech
· Advaxis, Inc.
· Precigen
· And Many Others
Request for Free Sample Report: https://www.delveinsight.com/sample-request/hpv-induced-cancers-market
· Gardasil
· Gardasil 9
· Cervarix
· PDS0101
· CUE-101
· ISA101b
· VB10.16
· TG4001
· VGX-3100
· HB-201
· HB-202
· UCPVax
· BNT113
· ADXS 11-001
· M7824
· PRGN-2009
· And Many More
Request for Free Sample Report: https://www.delveinsight.com/sample-request/hpv-induced-cancers-market
Table of Contents:
1. Key Insights
2. Executive Summary of HPV-Induced Cancers
3. Competitive Intelligence Analysis for HPV-Induced Cancers
4. HPV-Induced Cancers: Market Overview at a Glance
5. HPV-Induced Cancers: Disease Background and Overview
6. Patient Journey
7. HPV-Induced Cancers Epidemiology and Patient Population
8. Treatment Algorithm, Current Treatment, and Medical Practices
9. Unmet Needs
10. Key Endpoints of HPV-Induced Cancers Treatment
11. Marketed Products
List to be continued in report
12. Emerging Therapies
List to be continued in report
13. HPV-Induced Cancers: Seven Major Market Analysis
14. Attribute analysis
15. 7MM: Market Outlook
16. Access and Reimbursement Overview of HPV-Induced Cancers
17. KOL Views
18. Market Drivers
19. Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
23. About DelveInsight
Some of Newly Launched Report:
About Delveinsight:
DelveInsight Business Research is a leading Market Research, and Business Consultant focused purely on Healthcare. It helps pharma companies by providing them with end-to-end services to solve their business problems.
Get hold of all the Pharma and healthcare market research reports on our market research subscription-based platform PharmDelve.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: info@delveinsight.com
Phone: +19193216187
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/
Comments